June 9, 2022
RFA-OD-22-003, Center for Coordination of Analysis, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54 Clinical Trial Not Allowed)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)
The purpose of this notice is to inform potential applicants of corrections to RFA-OD-22-003, "Center for Coordination of Analysis, Science, Enhancement, and Logistics (CASEL) in Tobacco Regulatory Science (U54 Clinical Trial Not Allowed)" in the following sections, Section IV. Application and Submission Information 2. Content and Form of Application Submission.
Currently Reads
Page Limitations
Available Component Types |
Research Strategy/Program Plan Page Limits |
Overall (use for overview of the proposed Center) |
12 |
Admin Core (use for Leadership and Logistics Core) |
6 |
Analysis (use for Analysis and Rapid Response Core) |
6 |
Career Enhancement (use for Career Enhancement Core) |
6 |
Dissemination Core (use for Dissemination Core) |
6 |
Center-Named Core (use for Other Core(s)) |
6 |
Modified to Read (Revised Text in Bold Italics)
Available Component Types |
Research Strategy/Program Plan Page Limits |
Overall (use for overview of the proposed Center) |
12 |
Admin Core (use for Leadership and Logistics Core) |
6 |
Analysis (use for Analysis and Rapid Response Core) |
6 |
Career Enhancement (use for Career Enhancement Core) |
6 |
Dissemination Core (use for Dissemination Core) |
6 |
Center-Named Core (use for Center-Named Core(s)) |
6 |
Currently Reads
Instructions for the Submission of Multi-Component Applications
The following section supplements the instructions found in the SF424 (R&R) Application Guide, and should be used for preparing a multi-component application.
The application should consist of the following components:
Modified to Read (Revised Text in Bold Italics)
Instructions for the Submission of Multi-Component Applications
The following section supplements the instructions found in the SF424 (R&R) Application Guide, and should be used for preparing a multi-component application.
The application should consist of the following components:
Please direct all inquiries concerning this Notice to:
Helen Meissner, PhD
Office of Disease Prevention
Telephone: 301-451-8681
Email: [email protected]
All other inquiries concerning the FOA should be submitted to the Scientific/Research Contacts listed in the FOA.